Martin Samuel Bates bought CLDX

January 2, 2026 · Form 4 insider transaction

Martin Samuel Bates bought 4,817 shares of Celldex Therapeutics, Inc. at $10.38 per share, a transaction worth $50.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.